triphosphoric acid has been researched along with Congenital Zika Syndrome in 2 studies
triphosphoric acid: used as water softener, peptizing agent, emulsifier & dispersing agent; ingredient of cleansers; meat preservative; RN given refers to parent cpd; structure
| Excerpt | Relevance | Reference |
|---|---|---|
| "Galidesivir is an adenosine nucleoside analog that can attenuate flavivirus replication in cell-based assays and animal models of infection." | 5.91 | Galidesivir Triphosphate Promotes Stalling of Dengue-2 Virus Polymerase Immediately Prior to Incorporation. ( Bulloch, EMM; Deshpande, S; Evans, GB; Harris, LD; Huo, W; Kingston, RL; Shrestha, R; Sparrow, K; Wood, JM, 2023) |
| "Galidesivir is an adenosine nucleoside analog that can attenuate flavivirus replication in cell-based assays and animal models of infection." | 1.91 | Galidesivir Triphosphate Promotes Stalling of Dengue-2 Virus Polymerase Immediately Prior to Incorporation. ( Bulloch, EMM; Deshpande, S; Evans, GB; Harris, LD; Huo, W; Kingston, RL; Shrestha, R; Sparrow, K; Wood, JM, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deshpande, S | 1 |
| Huo, W | 1 |
| Shrestha, R | 1 |
| Sparrow, K | 1 |
| Wood, JM | 1 |
| Evans, GB | 1 |
| Harris, LD | 1 |
| Kingston, RL | 1 |
| Bulloch, EMM | 1 |
| Šebera, J | 1 |
| Dubankova, A | 1 |
| Sychrovský, V | 1 |
| Ruzek, D | 1 |
| Boura, E | 1 |
| Nencka, R | 1 |
2 other studies available for triphosphoric acid and Congenital Zika Syndrome
| Article | Year |
|---|---|
Galidesivir Triphosphate Promotes Stalling of Dengue-2 Virus Polymerase Immediately Prior to Incorporation.
Topics: Adenosine; Animals; Antiviral Agents; Dengue; Nucleotidyltransferases; RNA, Viral; Zika Virus; Zika | 2023 |
The structural model of Zika virus RNA-dependent RNA polymerase in complex with RNA for rational design of novel nucleotide inhibitors.
Topics: Adenosine; Humans; Magnesium; Models, Molecular; Molecular Docking Simulation; Nucleosides; Nucleoti | 2018 |